Ticker Details
Tarsus Pharmaceuticals, Inc. Common Stock
IPO Date:	October 12, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.19B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.98 | 2.98%
Avg Daily Range (30 D):	$1.65 | 2.65%
Avg Daily Range (90 D):	$1.57 | 2.48%

Institutional Daily Volume
Avg Daily Volume:	.31M
Avg Daily Volume (30 D):	.78M
Avg Daily Volume (90 D):	.69M

Trade Size
Avg Trade Size (Sh.):	56
Avg Trade Size (Sh.) (30 D):	55
Avg Trade Size (Sh.) (90 D):	55

Institutional Trades
Total Institutional Trades:	1,899
Avg Institutional Trade:	$3.34M
Avg Institutional Trade (30 D):	$3.33M
Avg Institutional Trade (90 D):	$4.91M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.56M
Avg Closing Trade (30 D):	$5.64M
Avg Closing Trade (90 D):	$5.8M
Avg Closing Volume:	78.2K

News

Aug 6, 2026 @ 12:02 AM Tarsus to Report Second Quarter 2026 Financial Res... Source: Na

May 7, 2026 @ 9:00 PM Tarsus to Participate in Upcoming Investor Confere... Source: Not Specified

Mar 24, 2026 @ 5:06 PM Tarsus Pharma Stock Up 20% as Insider Sells $839K ... Source: Jonathan Ponciano

Oct 28, 2025 @ 9:00 PM Tarsus to Report Third Quarter 2025 Financial Resu... Source: Tarsus Pharmaceuticals, Inc.

Oct 27, 2025 @ 3:15 PM Capricorn Fund Loads Up on Phreesia (PHR) With a 4... Source: Cory Renauer

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-1.08	$-.43	$-.16
Diluted EPS	$-1.08	$-.43	$-.16
Revenue	$606.33M	$173.91M	$162.05M
Gross Profit		$161.8M	$152.66M
Net Income / Loss	$-46.48M	$-18.55M	$-6.97M
Operating Income / Loss	$-48.54M	$-19.91M	$-6.12M
Cost of Revenue		$12.11M	$9.4M
Net Cash Flow	$107.39M	$102.4M	$-82.01M
PE Ratio